These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11139841)

  • 1. The affinity and selectivity of α-adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D-adrenoceptors.
    Proudman RGW; Pupo AS; Baker JG
    Pharmacol Res Perspect; 2020 Aug; 8(4):e00602. PubMed ID: 32608144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis.
    Mari A; Antonelli A; Cindolo L; Fusco F; Minervini A; De Nunzio C
    Ther Adv Urol; 2021; 13():1756287221993283. PubMed ID: 33912246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha1-adrenoceptor subtypes and lower urinary tract symptoms.
    Schwinn DA; Roehrborn CG
    Int J Urol; 2008 Mar; 15(3):193-9. PubMed ID: 18304211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia.
    Yu ZJ; Yan HL; Xu FH; Chao HC; Deng LH; Xu XD; Huang JB; Zeng T
    Front Pharmacol; 2020; 11():658. PubMed ID: 32457631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates in the function and regulation of α
    Akinaga J; García-Sáinz JA; S Pupo A
    Br J Pharmacol; 2019 Jul; 176(14):2343-2357. PubMed ID: 30740663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alpha
    Holanda VAD; Oliveira MC; de Oliveira Torres CI; de Almeida Moura C; Belchior H; da Silva Junior ED; Gavioli EC
    Behav Brain Res; 2024 Jul; 469():115027. PubMed ID: 38697302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased risk of bladder cancer in men treated with quinazoline-based α1-adrenoceptor antagonists.
    Martin FM; Harris AM; Rowland RG; Conner W; Lane M; Durbin E; Baron AT; Kyprianou N
    Gene Ther Mol Biol; 2008; 12(2):253-258. PubMed ID: 20717483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Considered by Experienced Urologists when Selecting Alpha-Blockers for Patients with Lower Urinary Tract Symptoms or Benign Prostatic Hyperplasia according to Age.
    Lee H; Lee JH; Choo MS; Cho MC; Son H; Jeong H; Yoo S
    Urol Int; 2024 May; ():1-8. PubMed ID: 38749410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Blocker Therapy: Current Update.
    Kaplan SA
    Rev Urol; 2005; 7 Suppl 8(Suppl 8):S34-42. PubMed ID: 16985889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Effects of Tamsulosin in Nightmare Disorder: A Randomized, Double Blind, Placebo-Controlled, Cross-Over, Pilot Study.
    Naderifar N; Roohi E; Sharifi A; Jaafari N; Hashemian F
    Drug Res (Stuttg); 2024 Feb; 74(2):53-59. PubMed ID: 38237637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocyte Alpha-1A Adrenergic Receptors Mitigate Postinfarct Remodeling and Mortality by Constraining Necroptosis.
    Zhang J; Sandroni PB; Huang W; Gao X; Oswalt L; Schroder MA; Lee S; Shih YI; Huang HS; Swigart PM; Myagmar BE; Simpson PC; Rossi JS; Schisler JC; Jensen BC
    JACC Basic Transl Sci; 2024 Jan; 9(1):78-96. PubMed ID: 38362342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycolysis-enhancing α
    Weber MA; Sivakumar K; Tabakovic EE; Oya M; Aldridge GM; Zhang Q; Simmering JE; Narayanan NS
    NPJ Parkinsons Dis; 2023 Mar; 9(1):32. PubMed ID: 36864060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of silodosin in the medical expulsion therapy for distal ureteral calculi: a systematic review and meta-analysis.
    Huang W; Xue P; Zong H; Zhang Y
    Br J Clin Pharmacol; 2016 Jan; 81(1):13-22. PubMed ID: 26255996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Quinazoline-Based Fluorescent Probes to α1-Adrenergic Receptors.
    Zhang W; Ma Z; Li W; Li G; Chen L; Liu Z; Du L; Li M
    ACS Med Chem Lett; 2015 May; 6(5):502-6. PubMed ID: 26005522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of alpha 1 adrenergic receptors on urinary bladder in rat spinal cord injury model.
    Lee G; Park H; Park HS; Lee JG
    Int Neurourol J; 2012 Jun; 16(2):62-8. PubMed ID: 22816046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alfuzosin: a review of the therapeutic use of the prolonged-release formulation given once daily in the management of benign prostatic hyperplasia.
    McKeage K; Plosker GL
    Drugs; 2002; 62(4):633-53. PubMed ID: 11893233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia.
    Forray C; Noble SA
    Expert Opin Investig Drugs; 1999 Dec; 8(12):2073-2094. PubMed ID: 11139841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical pharmacology of alpha1-adrenoceptor antagonists.
    Martin DJ
    Eur Urol; 1999; 36 Suppl 1():35-41; discussion 65. PubMed ID: 10393471
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.